D. Vesole: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphoma

Jed A. Katzel, Sanford J. Kempin, Portia Lagmay-Fuentes, William A. Cook, Frederick P. Siegal, Lizette E. Henriquez, Moon H. Lee, David H. Vesole

Journal:

American Journal of Hematology

Year:

2008

Language:

english

File:

PDF, 254 KB

english, 2008

2

Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma

William I. Bensinger, Sundar Jagannath, Robert Vescio, Elber Camacho, Jeffrey Wolf, David Irwin, Gerardo Capo, Marti McKinley, Phyllis Potts, David H. Vesole, Amitabha Mazumder, John Crowley, Pam Beck

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 155 KB

english, 2010

3

Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study

Vesole, D H, Oken, M M, Heckler, C, Greipp, P R, Katz, M S, Jacobus, S, Morrow, G R

Journal:

Year:

2012

Language:

english

File:

PDF, 295 KB

english, 2012

4

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up

Biran, N, Jacobus, S, Vesole, D H, Callander, N S, Fonseca, R, Williams, M E, Abonour, R, Katz, M S, Rajkumar, S V, Greipp, P R, Siegel, D S

Journal:

Blood Cancer Journal

Year:

2016

Language:

english

File:

PDF, 473 KB

english, 2016

5

Role of 18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

Cavo, Michele, Terpos, Evangelos, Nanni, Cristina, Moreau, Philippe, Lentzsch, Suzanne, Zweegman, Sonja, Hillengass, Jens, Engelhardt, Monika, Usmani, Saad Z, Vesole, David H, San-Miguel, Jesus, Kumar

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 207 KB

english, 2017

6

Effect of low-dose granulocyte-macrophage colony-stimulating factor (LD-GM-CSF) on platelet transfusion-dependent thrombocytopenia

David H. Vesole, Sundar Jagannath, Luther D. Glenn, Bart Barlogie

Journal:

American Journal of Hematology

Year:

1994

Language:

english

File:

PDF, 410 KB

english, 1994

7

Initial immunoglobulin M ‘flare’ after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia : An Eastern Cooperative Oncology Group Study

Irene M. Ghobrial, Rafael Fonseca, Philip R. Greipp, Emily Blood, Montserrat Rue, David H. Vesole, Morie A. Gertz

Journal:

Year:

2004

Language:

english

File:

PDF, 98 KB

english, 2004

8

Toxoplasma pneumonia: Cytologic diagnosis by bronchoalveolar lavage

Rebecca R. Wheeler, Ricardo H. Bardales, Paula E. North, David H. Vesole, Guido Tricot, Michael W. Stanley

Journal:

Diagnostic Cytopathology

Year:

1994

Language:

english

File:

PDF, 307 KB

english, 1994

9

Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma

Rangaswamy Govindarajan, Sundar Jagannath, James T. Flick, David H. Vesole, Jeffrey Sawyer, Bart Barlogie, Guido Tricot

Journal:

British Journal of Haematology

Year:

1996

Language:

english

File:

PDF, 304 KB

english, 1996

10

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH-DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan BladÉ, Diana Samson, Donna Reece, Jane Apperley, Bo BJÖrkstrand, GÖsta Gahrton, Morie Gertz, Sergio Giralt, SUNDARr Jagannath, David Vesole, On behalf of the Myeloma, Subcommittee of the EBMT, (E

Journal:

British Journal of Haematology

Year:

1998

Language:

english

File:

PDF, 341 KB

english, 1998

11

Acute tumour lysis syndrome: a case in AL amyloidosis

Marwan S. Akasheh, Chi P. Chang, David H. Vesole

Journal:

British Journal of Haematology

Year:

1999

Language:

english

File:

PDF, 52 KB

english, 1999

12

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

K. R. Desikan, G. Tricot, N. C. Munshi, E. Anaissie, D. Spoon, A. Fassas, A. Toor, M. Zangari, A. Badros, C. Morris, D. H. Vesole, D. Siegel, S. Jagannath, B. Barlogie

Journal:

British Journal of Haematology

Year:

2001

Language:

english

File:

PDF, 154 KB

english, 2001

13

Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience

Athanasios B.-T. Fassas, Bart Barlogie, Susan Ward, Sundar Jagannath, David Vesole, Sandy Mattox, David Siegel, Firas Muwalla, Maurizio Zangari, Elias Anaissie, Frits Van Rhee, Raymond Thertulien, Cho

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

14

Relapsed multiple myeloma

Sandeep Pandit, David H. Vesole

Journal:

Current Treatment Options in Oncology

Year:

2001

Language:

english

File:

PDF, 277 KB

english, 2001

15

Management of renal dysfunction in multiple myeloma

Sandeep R. Pandit, David H. Vesole

Journal:

Current Treatment Options in Oncology

Year:

2003

Language:

english

File:

PDF, 290 KB

english, 2003

16

Long-term outcome results of the first tandem autotransplant trial for multiple myeloma

Bart Barlogie, Guido J. Tricot, Frits Van Rhee, Edguardo Angtuaco, Ron Walker, Joshua Epstein, John D. Shaughnessy, Sundar Jagannath, Vanessa Bolejack, Jennifer Gurley, Antje Hoering, David Vesole, Ra

Journal:

British Journal of Haematology

Year:

2006

Language:

english

File:

PDF, 2.11 MB

english, 2006

17

Bortezomib disrupts tumour–dendritic cell interactions in myeloma and lymphoma: therapeutic implications

Anjli Kukreja, Aisha Hutchinson, Amitabha Mazumder, David Vesole, Revathi Angitapalli, Sundar Jagannath, Owen A. O'Connor, Madhav V. Dhodapkar

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 524 KB

english, 2007

18

A Lymphocyte Growth Factor Made by a Human Lymphoid Cell Line

Richard Sanderson, David Vesole, James Jakway, David Talmage

Journal:

Immunological Reviews

Year:

1980

Language:

english

File:

PDF, 3.13 MB

english, 1980

19

Plasma exchange after hematopoietic stem cell transplantation in multiple myeloma to reduce renal insufficiency

Sullivan, K, Jagannath, S, Mazumder, A, Vesole, D H

Journal:

Bone Marrow Transplantation

Year:

2008

Language:

english

File:

PDF, 66 KB

english, 2008

20

Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial

Dispenzieri, A, Jacobus, S, Vesole, D H, Callandar, N, Fonseca, R, Greipp, P R

Journal:

Year:

2010

Language:

english

File:

PDF, 327 KB

english, 2010

21

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Kyle, R A, Durie, B G M, Rajkumar, S V, Landgren, O, Blade, J, Merlini, G, Kröger, N, Einsele, H, Vesole, D H, Dimopoulos, M

Journal:

Year:

2010

Language:

english

File:

PDF, 307 KB

english, 2010

22

Peripheral stem cell mobilization and engraftment in patients over age 60

Guba, S C, Vesole, D H, Jagannath, S, Bracy, D, Barlogie, B, Tricot, G

Journal:

Bone Marrow Transplantation

Year:

1997

Language:

english

File:

PDF, 81 KB

english, 1997

23

High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant

Mehta, J, Tricot, G, Jagannath, S, Desikan, K R, Siegel, D, Singhal, S, Munshi, N, Vesole, D, Mattox, S, Bracy, D

Journal:

Bone Marrow Transplantation

Year:

1997

Language:

english

File:

PDF, 89 KB

english, 1997

24

Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

Jagannath, S, Vesole, D H, Zhang, M, Desikan, K R, Copeland, N, Jagannath, M, Bracy, D, Jones, R, Crowley, J, Tricot, G

Journal:

Bone Marrow Transplantation

Year:

1997

Language:

english

File:

PDF, 153 KB

english, 1997

25

Accelerated atherosclerosis in a patient with post-BMT nephropathy

Akasheh, M, Priyanath, A, Pello, N, Watry, P, Vesole, D

Journal:

Bone Marrow Transplantation

Year:

1999

Language:

english

File:

PDF, 30 KB

english, 1999

26

Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone

Desikan, K R, Tricot, G, Dhodapkar, M, Fassas, A, Siegel, D, Vesole, D H, Jagannath, S, Singhal, S, Mehta, J, Spoon, D

Journal:

Bone Marrow Transplantation

Year:

2000

Language:

english

File:

PDF, 64 KB

english, 2000

27

Cunninghamella infection post bone marrow transplant: case report and review of the literature

Darrisaw, L, Hanson, G, Vesole, D H, Kehl, S C

Journal:

Bone Marrow Transplantation

Year:

2000

Language:

english

File:

PDF, 113 KB

english, 2000

28

Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation

Akasheh, M S, Freytes, C O, Vesole, D H

Journal:

Bone Marrow Transplantation

Year:

2000

Language:

english

File:

PDF, 39 KB

english, 2000

29

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts

Vesole, D H, Simic, A, Lazarus, H M

Journal:

Bone Marrow Transplantation

Year:

2001

Language:

english

File:

PDF, 137 KB

english, 2001

30

Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF)

Akasheh, M, Eastwood, D, Vesole, D H

Journal:

Bone Marrow Transplantation

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

31

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

Burns, L J, Weisdorf, D J, DeFor, T E, Vesole, D H, Repka, T L, Blazar, B R, Burger, S R, Panoskaltsis-Mortari, A, Keever-Taylor, C A, Zhang, M-J

Journal:

Bone Marrow Transplantation

Year:

2003

Language:

english

File:

PDF, 183 KB

english, 2003

32

A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study

Gertz, M A, Blood, E, Vesole, D H, Abonour, R, Lazarus, H M, Greipp, P R

Journal:

Bone Marrow Transplantation

Year:

2004

Language:

english

File:

PDF, 121 KB

english, 2004

33

Outcome of unrelated transplants in patients with multiple myeloma

Ballen, K K, King, R, Carston, M, Kollman, C, Nelson, G, Lim, S, Reece, D, Giralt, S, Vesole, D H

Journal:

Bone Marrow Transplantation

Year:

2005

Language:

english

File:

PDF, 131 KB

english, 2005

34

The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells

McGregor, D K, Keever-Taylor, C A, Bredeson, C, Schur, B, Vesole, D H, Logan, B, Chang, C-C

Journal:

Bone Marrow Transplantation

Year:

2005

Language:

english

File:

PDF, 138 KB

english, 2005

35

Cure of multiple myeloma – more hype, less reality

Hari, P, Pasquini, M C, Vesole, D H

Journal:

Bone Marrow Transplantation

Year:

2005

Language:

english

File:

PDF, 246 KB

english, 2005

36

Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients

Mazumder, A, Kaufman, J, Niesvizky, R, Lonial, S, Vesole, D, Jagannath, S

Journal:

Year:

2007

Language:

english

File:

PDF, 75 KB

english, 2007

37

Phase I study for poor-prognosis lymphoma: Augmentation of the “BEAM” regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation — a preliminary report

G.L. Phillips II, C.N. Abboud, S.H. Bernstein, J.W. Friedberg, J.J. Ifthikharuddin, J.E. Lancet, J.L. Liesveld, E. Spreng, V. Johnson, M. Chapman, D.H. Vesole

Journal:

Seminars in Oncology

Year:

2004

Language:

english

File:

PDF, 82 KB

english, 2004

38

Multiple Myeloma: Charging Toward a Bright Future

Dr. Jed A. Katzel, Dr. Parameswaran Hari, Dr. David H. Vesole

Journal:

CA: A Cancer Journal for Clinicians

Year:

2007

Language:

english

File:

PDF, 283 KB

english, 2007

39

Multiple Myeloma: An Old Disease with New Hope for the Future

Dr. Adnan A. Zaidi, Dr. David H. Vesole

Journal:

CA: A Cancer Journal for Clinicians

Year:

2001

Language:

english

File:

PDF, 108 KB

english, 2001

40

Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia

Roccaro, A. M., Sacco, A., Husu, E. N., Pitsillides, C., Vesole, S., Azab, A. K., Azab, F., Melhem, M., Ngo, H. T., Quang, P.

Journal:

Year:

2010

Language:

english

File:

PDF, 2.41 MB

english, 2010

41

Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the phase III sprint trial of intercept pathogen inactivated platelets

D Vesole, E Stadtmauer, L.T Goodnough, S Coutre, F Howard, J.-S Lin, M.G Conlan

Journal:

Biology of Blood and Marrow Transplantation

Year:

2004

Language:

english

File:

PDF, 62 KB

english, 2004

42

Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): A multicenter trial

S. Durrant, D. Vesole, A. Langston, J.H. Lipton, H. Patino, L. Pedicone, A.J. Ullmann

Journal:

Biology of Blood and Marrow Transplantation

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

43

A Phase II Trial of Autologous Stem Cell Transplantation Followed by Mini-Allogeneic Stem Cell Transplantation for the Treatment of Multiple Myeloma: An Analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97

David H. Vesole, Lijun Zhang, Neal Flomenberg, Philip R. Greipp, Hillard M. Lazarus

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 235 KB

english, 2009

44

Allogeneic Stem Cell Transplantion In Relapsed/Refractory Acute Leukemia: A Long Term Single Institution Experience

A. Go, P.J. Stiff, M. Parthasarathy, T.E. Rodriguez, S.E. Smith, M. Brush, K. Kiley, M. Payan, N. Porter, M. Volle, D.H. Vesole

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 65 KB

english, 2009

45

Salvage and Hematopoietic Recovery With Bortezomib and Melphalan In Cytopenic Recurrent and Refractory Multiple Myeloma

A. Mazumder, D. Vesole, S. Jagannath

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 60 KB

english, 2009

46

Allotransplants Using Ablative Non-Radiation Based Reduced Toxicity Conditioning Regimen with Intravenous Busulfan Plus Pentostatin for Patients with Advanced Hematologic Malignancies

A.T. Gerds, T.E. Rodriguez, M. Parthasarathy, S.E. Smith, D.H. Vesole, P.J. Stiff

Journal:

Biology of Blood and Marrow Transplantation

Year:

2009

Language:

english

File:

PDF, 51 KB

english, 2009

47

A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection

Gordon L. Phillips II, Steven H. Bernstein, Jane L. Liesveld, Camille N. Abboud, Michael W. Becker, Louis S. Constine, J.J. Ifthikharuddin, John E. Loughner, Laurie A. Milner, David H. Vesole, Jonatha

Journal:

Biology of Blood and Marrow Transplantation

Year:

2011

Language:

english

File:

PDF, 319 KB

english, 2011

48

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

S Vincent Rajkumar, Susanna Jacobus, Natalie S Callander, Rafael Fonseca, David H Vesole, Michael E Williams, Rafat Abonour, David S Siegel, Michael Katz, Philip R Greipp

Journal:

The Lancet Oncology

Year:

2010

Language:

english

File:

PDF, 125 KB

english, 2010

49

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

Amrita Krishnan, Marcelo C Pasquini, Brent Logan, Edward A Stadtmauer, David H Vesole, Edwin Alyea 3rd, Joseph H Antin, Raymond Comenzo, Stacey Goodman, Parameswaran Hari, Ginna Laport, Muzaffar H Qaz

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 272 KB

english, 2011

50

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion

Carolyn A Keever-Taylor, Christopher Bredeson, Fausto R Loberiza, James T Casper, Colleen Lawton, Douglas Rizzo, William H Burns, David A Margolis, David H Vesole, Mary Horowitz, Mei-Jie Zhang, Mark J

Journal:

Biology of Blood and Marrow Transplantation

Year:

2001

Language:

english

File:

PDF, 191 KB

english, 2001

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски